We evaluated the expression of HDAC10 in 33 different types of tumors, which showing that HDAC10 expression varied significantly in 18 different tumors, including Bladder Urothelial Carcinoma (BLCA), Colon adenocarcinoma (COAD), Liver hepatocellular carcinoma (LIHC), Lung adenocarcinoma (LUAD) and KIRC (Fig. 2B). Here, HDAC10 is linked to bladder transitional cell carcinoma.